Analyst Consensus ?
ConsensusBuy43 ratings
Bullish3479.1%
Neutral920.9%
Bearish00.0%
FN2 Earnings Intelligence
Abbott Laboratories analyst ratings
Abbott Laboratories (ABT) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$104.88Current
$24.01Low
$126.68Average
$158High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 22, 2026 |
| BTIG | Buy | Buy | Maintain | Oct 22, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 22, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | Oct 2, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 13, 2026 |
| UBS | Buy | Buy | Maintain | Jul 28, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | May 31, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 20, 2026 |
| Stifel | Buy | Buy | Maintain | Apr 17, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 17, 2026 |
| Benchmark | Buy | Buy | Maintain | Apr 17, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 17, 2026 |
| Freedom Broker | Buy | Hold | Upgrade | Jan 29, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 23, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Oct 16, 2025 |
| Mizuho | Neutral | Neutral | Maintain | Jul 18, 2025 |
| Jefferies | Buy | Hold | Upgrade | Jul 18, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 15, 2025 |
| Argus Research | Buy | Buy | Maintain | Jul 28, 2022 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Apr 21, 2022 |
| CFRA | Buy | Buy | Maintain | Apr 20, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 27, 2022 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Oct 27, 2021 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 28, 2021 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 23, 2020 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Jan 2, 2020 |
| Guggenheim | Neutral | Buy | Downgrade | Jan 2, 2020 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 18, 2019 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| William Blair | Outperform | Market Perform | Upgrade | Jan 25, 2018 |
| BTIG Research | Neutral | Buy | Downgrade | Jan 22, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 21, 2017 |
| Edward Jones | Buy | Hold | Upgrade | Jun 21, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Apr 28, 2016 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Jan 25, 2016 |
| Gabelli & Co. | Buy | Buy | Maintain | May 21, 2013 |
| Bank oferica | Neutral | Neutral | Maintain | Apr 5, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $104.88. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $120 | $103.08 | +14.4% | Oct 23, 2026 |
| Wells Fargo | Analyst unavailable | $120 | $102.51 | +14.4% | Oct 23, 2026 |
| BTIG | Marie Thibault | $125 | $100.57 | +19.2% | Oct 22, 2026 |
| Wells Fargo | Analyst unavailable | $119 | $100.57 | +13.5% | Oct 22, 2026 |
| Robert W. Baird | Analyst unavailable | $123 | $100.57 | +17.3% | Oct 22, 2026 |
| New Street | Analyst unavailable | $120 | $104.6 | +14.4% | Oct 16, 2026 |
| Barclays | Analyst unavailable | $120 | $98.17 | +14.4% | Oct 6, 2026 |
| Redburn Partners | Ed Ridley-Day | $127 | $96.71 | +21.1% | Oct 2, 2026 |
| Wolfe Research | Analyst unavailable | $130 | $110.92 | +24.0% | Aug 13, 2026 |
| UBS | Patrick Wood | $125 | $108.84 | +19.2% | Jul 28, 2026 |
| Benchmark Co. | Analyst unavailable | $120 | $100.67 | +14.4% | Jul 20, 2026 |
| Piper Sandler | Analyst unavailable | $118 | $98.82 | +12.5% | Jul 17, 2026 |
| BTIG | Analyst unavailable | $134 | $98.82 | +27.8% | Jul 16, 2026 |
| Evercore ISI | Vijay Kumar | $112 | $93.64 | +6.8% | Jul 6, 2026 |
| Robert W. Baird | David Rescott | $121 | $90.68 | +15.4% | Jun 30, 2026 |
| Daiwa | Analyst unavailable | $92 | $92.74 | -12.3% | Apr 22, 2026 |
| Barclays | Matt Miksic | $143 | $96.83 | +36.3% | Apr 20, 2026 |
| UBS | Analyst unavailable | $115 | $95.46 | +9.6% | Apr 17, 2026 |
| Piper Sandler | Analyst unavailable | $115 | $95.46 | +9.6% | Apr 17, 2026 |
| Stifel Nicolaus | Analyst unavailable | $120 | $95.46 | +14.4% | Apr 17, 2026 |
| UBS | Danielle Antalffy | $158 | $108.42 | +50.6% | Mar 13, 2026 |
| New Street | Analyst unavailable | $145 | $108.14 | +38.3% | Mar 13, 2026 |
| Barclays | Analyst unavailable | $142 | $109.3 | +35.4% | Feb 2, 2026 |
| Loop Capital Markets | Ilya Zubkov | $120 | $106.09 | +14.4% | Jan 29, 2026 |
| Evercore ISI | Analyst unavailable | $138 | $108.61 | +31.6% | Jan 23, 2026 |
| UBS | Analyst unavailable | $132 | $108.6 | +25.9% | Jan 23, 2026 |
| Mizuho Securities | Anthony Petrone | $125 | $108.6 | +19.2% | Jan 23, 2026 |
| Piper Sandler | Analyst unavailable | $135 | $108.6 | +28.7% | Jan 23, 2026 |
| Bernstein | Analyst unavailable | $125 | $108.6 | +19.2% | Jan 23, 2026 |
| Wells Fargo | Larry Biegelsen | $122 | $108.6 | +16.3% | Jan 23, 2026 |
| Bernstein | Lee Hambright | $154 | $126.18 | +46.8% | Jan 9, 2026 |
| Goldman Sachs | Analyst unavailable | $152 | $126.18 | +44.9% | Jan 9, 2026 |
| Evercore ISI | Analyst unavailable | $144 | $123.97 | +37.3% | Jan 5, 2026 |
| Barclays | Analyst unavailable | $169 | $124.19 | +61.1% | Jan 5, 2026 |
| BTIG | Marie Thibault | $145 | $126.24 | +38.3% | Dec 22, 2025 |
| Tigress Financial | Analyst unavailable | $145 | $128.12 | +38.3% | Nov 21, 2025 |
| Barclays | Analyst unavailable | $162 | $127.63 | +54.5% | Oct 17, 2025 |
| Wells Fargo | Analyst unavailable | $146 | $129.45 | +39.2% | Oct 16, 2025 |
| Goldman Sachs | Analyst unavailable | $157 | $133.94 | +49.7% | Oct 1, 2025 |
| RBC Capital | Shagun Singh | $147 | $131.49 | +40.2% | Jul 15, 2025 |
| RBC Capital | Shagun Singh | $140 | $126.22 | +33.5% | Apr 15, 2025 |
| Bernstein | Lee Hambright | $135 | $114.25 | +28.7% | Jan 8, 2025 |
| Piper Sandler | Adam Maeder | $133 | $117.82 | +26.8% | Oct 17, 2024 |
| Bernstein | Lee Hambright | $138 | $117.82 | +31.6% | Oct 17, 2024 |
| Jefferies | Matthew Taylor | $125 | $117.82 | +19.2% | Oct 16, 2024 |
| Evercore ISI | Vijay Kumar | $128 | $117.82 | +22.0% | Oct 16, 2024 |
| BTIG | Marie Thibault | $139 | $117.82 | +32.5% | Oct 16, 2024 |
| Oppenheimer | Suraj Kalia | $130 | $114.3 | +24.0% | Oct 8, 2024 |
| RBC Capital | Shagun Singh | $130 | $113.36 | +24.0% | Oct 8, 2024 |
| Roth Capital | Scott Fortune | $24.01 | $54.49 | -77.1% | Sep 19, 2024 |
| Piper Sandler | Adam Maeder | $131 | $114.88 | +24.9% | Sep 19, 2024 |
| Jefferies | Matthew Taylor | $120 | $112.22 | +14.4% | Aug 27, 2024 |
| Citigroup | Joanne Wuensch | $127 | $111.39 | +21.1% | Aug 22, 2024 |
| Citigroup | Joanna Wiensch | $119 | $104.68 | +13.5% | Jul 18, 2024 |
| Evercore ISI | Vijay Kumar | $120 | $103.2 | +14.4% | Jul 2, 2024 |
| BTIG | Marie Thibault | $135 | $102.99 | +28.7% | Jun 3, 2024 |
| Goldman Sachs | David Roman | $121 | $100.73 | +15.4% | May 30, 2024 |
| Barclays | Matt Miksic | $140 | $107.07 | +33.5% | Apr 22, 2024 |
| Bernstein | Lee Hambright | $133 | $105.27 | +26.8% | Apr 18, 2024 |
| RBC Capital | Shagun Singh | $125 | $105.9 | +19.2% | Apr 18, 2024 |
| Morgan Stanley | Analyst unavailable | $133 | $111.37 | +26.8% | Jan 6, 2023 |
| Citigroup | Analyst unavailable | $125 | $107.51 | +19.2% | Dec 12, 2022 |
| RBC Capital | Shagun Singh | $132 | $109.78 | +25.9% | Aug 3, 2022 |
| UBS | Analyst unavailable | $128 | $109.09 | +22.0% | Jul 27, 2022 |
| Citigroup | Analyst unavailable | $123 | $108.23 | +17.3% | Jul 21, 2022 |
| BTIG | Analyst unavailable | $126 | $108.36 | +20.1% | Jul 18, 2022 |
| Stifel Nicolaus | Analyst unavailable | $126 | $108.43 | +20.1% | Jul 18, 2022 |
| Raymond James | Analyst unavailable | $117 | $105.71 | +11.6% | Jul 15, 2022 |
| BTIG | Marie Thibault | $130 | $109.45 | +24.0% | Jun 27, 2022 |
| Raymond James | Jayson Bedford | $135 | $119.64 | +28.7% | Apr 25, 2022 |
| RBC Capital | Analyst unavailable | $143 | $122.64 | +36.3% | Apr 21, 2022 |
| BTIG | Marie Thibault | $140 | $123.8 | +33.5% | Apr 21, 2022 |
| New Street | Analyst unavailable | $117.49 | $123.41 | +12.0% | Apr 20, 2022 |
| Wells Fargo | Larry Biegelsen | $150 | $120.04 | +43.0% | Apr 11, 2022 |
| Bank of America Securities | Travis Steed | $140 | $120.97 | +33.5% | Mar 3, 2022 |
| Morgan Stanley | Cecilia Furlong | $151 | $122.41 | +44.0% | Feb 26, 2022 |
| Raymond James | Jayson Bedford | $143 | $129.71 | +36.3% | Feb 6, 2022 |
| Citigroup | Joanne Wuensch | $154 | $135.08 | +46.8% | Dec 15, 2021 |
| Jefferies | Raj Denhoy | $145 | $124.61 | +38.3% | Oct 21, 2021 |
| Stifel Nicolaus | Rick Wise | $130 | $117.38 | +24.0% | Jul 22, 2021 |
| Goldman Sachs | Amit Hazan | $120 | $104.61 | +14.4% | Jun 1, 2021 |
| Evercore ISI | Vijay Kumar | $136 | $121.24 | +29.7% | Apr 21, 2021 |
Track every rating change on ABT the moment it posts. Free to start.
Start freeGet the ABT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.